EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges

Sana Younus, Lauren Havel, Jordan T Stiede, Catherine E Rast, Kirti Saxena, Wayne K Goodman, Eric A Storch

Pediatric Drugs · 2024

DOI: 10.1007/s40272-024-00639-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Drugs, 2024. Verfasst von Sana Younus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1977 Butler Blvd, Suite 4-400, Houston, TX, 77030, USA. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, Antipsychotic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: Eunice Kennedy Shriver National Institute of Child Health and Human Development, International OCD Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric obsessive-compulsive disorder (OCD) is a chronic, potentially debilitating psychiatric condition. Although effective treatments exist, at least 10% of youth do not achieve remission despite receiving first-line treatments. This article reviews the extant, albeit limited, evidence supporting treatment approaches for youth with treatment-resistant OCD. A literature search for articles addressing pediatric treatment-resistant OCD was conducted through April 11, 2024. These results were augmented by searching for treatment-resistant OCD in adults; treatment strategies discovered for the adult population were then searched in the context of children and adolescents. In general, intensive treatment programs and antipsychotic augmentation of an antidepressant had the most substantial and consistent evidence base for treatment-resistant youth with OCD, although studies were limited and of relatively poor methodological quality (i.e., open trials, naturalistic studies). Several pharmacological approaches (clomipramine, antipsychotics [e.g., aripiprazole, risperidone], riluzole, ketamine, D-cycloserine, memantine, topiramate, N-acetylcysteine, ondansetron), largely based on supporting data among adults, have received varying levels of investigation and support. There is nascent support for how to treat pediatric treatment-resistant OCD. Future treatment studies need to consider how to manage the significant minority of youth who fail to benefit from first-line treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obsessive-Compulsive DisorderAntipsychotic AgentsHumansChildAdolescentAntidepressive Agents

Substanzen

Antipsychotic AgentsAntidepressive Agents

Autor:innen und Institutionen

  • Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1977 Butler Blvd, Suite 4-400, Houston, TX, 77030, USA.
  • Texas Children's Hospital, Houston, TX, USA.
  • Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1977 Butler Blvd, Suite 4-400, Houston, TX, 77030, USA. eric.storch@bcm.edu.

Förderung

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • International OCD Foundation

Zitieren

APA

Younus, S., Havel, L., Stiede, J. T., Rast, C. E., Saxena, K., Goodman, W. K., & Storch, E. A. (2024). Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges. Pediatric Drugs. https://doi.org/10.1007/s40272-024-00639-5

Vancouver

Younus S, Havel L, Stiede JT, Rast CE, Saxena K, Goodman WK, et al. Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges. Pediatric Drugs. 2024. doi:10.1007/s40272-024-00639-5

BibTeX
@article{Younus2024,
  author = {Younus, Sana and Havel, Lauren and Stiede, Jordan T and Rast, Catherine E and Saxena, Kirti and Goodman, Wayne K and Storch, Eric A},
  title = {Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges},
  journal = {Pediatric Drugs},
  year = {2024},
  doi = {10.1007/s40272-024-00639-5}
}
Kostenlos starten →